Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

868
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
868
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

868
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
868
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

245
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
245
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

359
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
359
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

542
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
542
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

311
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
311

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Assessing the concordance between ChatGPT-4 and EAU guidelines indications in bladder cancer management: a real-world study.

Minerva urology and nephrology·2026
Same author

Contemporary Practices in the Assessment and Management of Climacturia: Results from an International Survey.

European urology open science·2026
Same author

Performance of artificial intelligence chatbots compared with young academic urologists in reconstructive urology.

The French journal of urology·2026
Same author

Redefining clinical success in minimally invasive surgery for BPH: A composite endpoint integrating ejaculatory function, urinary improvement, and safety metrics.

Urologia·2026
Same author

Beyond surgery: the international masterclass in andrology and reconstructive surgery (iMARS) and the value of global collaboration in reconstructive urology and sexual medicine.

International journal of impotence research·2026
Same author

Urethral Complications After Masculinizing Genital Gender-affirming Surgery.

European urology focus·2026

相关实验视频

Updated: Jan 13, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

785

隔离食后脂质不良症与勃起功能障碍之间的关联

Celeste Manfredi1, Giampiero Della Rosa1, Simone Tammaro1

  • 1Department of Woman, Child and General and Specialized Surgery, Unit of Urology, University of Campania "Luigi Vanvitelli", Naples, Italy.

Andrology
|January 10, 2026
PubMed
概括

隔离性餐后脂质失调症 (IPD) 与勃起功能障碍 (ED) 的患病率和严重程度增加有关,类似于慢性脂质失调症. 餐后脂质检测可以揭示影响性健康的代谢风险.

关键词:
心脏代谢风险心脏代谢风险这是勃起功能障碍.脂质特征 脂质特征 脂质特征吃饭后的脂质失调症是什么

更多相关视频

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
09:49

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

3.9K

相关实验视频

Last Updated: Jan 13, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

785
Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
09:49

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

3.9K

科学领域:

  • 心血管健康 心血管健康
  • 代谢综合征是代谢综合征的一种.
  • 性医学性医学性医学性医学

背景情况:

  • 餐后脂质检测是一种公认的血管健康标志物.
  • 餐后失脂症和勃起功能障碍 (ED) 之间的联系还没有得到充分研究.
  • 隔离性食后脂质失调 (IPD) 可能会错过禁食测试,尽管有异位风险.

研究的目的:

  • 为了调查IPD和勃起功能之间的关联.
  • 为了比较ED患有IPD,结合性脂质失调 (CD) 和没有脂质失调 (WD) 的男性的发病率和严重程度.

主要方法:

  • 在351名年龄≥18岁的男性中进行了横截面研究.
  • 包括当天禁食和食后脂质检测以及IIEF-EF勃起功能问卷.
  • 根据失脂症标准分类为WD,IPD和CD组;多变量逻辑回归分析.

主要成果:

  • 在IPD (55.1%) 和CD (57.0%) 组中,ED的患病率明显高于WD (32.8%).
  • 与WD相比,IPD和CD组的IIEF-EF中位数较低,具有统计学上显著和临床上有意义的差异.
  • 调整后的分析显示,与WD相比,IPD和CD组的ED概率增加;ED严重程度也更高.

结论:

  • IPD与ED的患病率和严重程度有关,类似于慢性失脂症.
  • 餐后脂质检测可以确定与性健康相关的代谢风险.
  • 建议在ED评估中考虑食后脂质检测.